FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Med Sci / Bone marrow-derived multipotent mesenchymal stromal cells fr...
Veterinary medicine and science2017; 3(4); 239-251; doi: 10.1002/vms3.74

Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia.

Abstract: Allogeneic equine multipotent mesenchymal stromal cells (eMSCs) have been proposed for use in regenerative therapies in veterinary medicine. A source of allogeneic eMSCs might be the bone marrow from euthanized horses. The purpose of this study was to compare characteristics of equine bone marrow derived eMSC (eBM-MSCs) from euthanized horses (eut-MSCs) and from narcotized horses (nar-MSCs). Eut-MSCs and nar-MSCs showed typical eMSC marker profiles (positive: CD44, CD90; negative: CD11a/CD18 and MHCII) and possessed tri-lineage differentiation characteristics. Although CD105 and MHCI expression varied, no differences were detected between eut-MSCs and nar-MSCs. Proliferation characteristics did not differ between eut-MSCs and nar-MSCs, but age dependent decrease in proliferation and increase in MHCI expression was detected. These results suggest the possible use of eut-MSCs for therapeutic applications and production of commercial available eBM-MSC products.
Get Full Text
Publication Date: 2017-09-12 PubMed ID: 29152317PubMed Central: PMC5677777DOI: 10.1002/vms3.74Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studied the characteristics of equine bone marrow-derived multipotent mesenchymal stromal cells (eBM-MSCs) extracted from euthanized horses, intending to assess whether they could serve as a viable source of cells for regenerative therapies in veterinary medicine. The findings indicated similar characteristics and proliferation rates between these cells and those derived from narcotized horses, with an age-dependent decrease in proliferation and increase in MHCI expression.

Introduction and Objective

  • The research aimed to explore potential uses of equine multipotent mesenchymal stromal cells (eMSCs) sourced from the bone marrow of horses after euthanasia, with regenerative therapies in veterinary medicine being a primary objective.

Methodology

  • Researchers compared attributes of equine bone marrow-derived MSCs (eBM-MSCs) obtained from euthanized horses (eut-MSCs) with those extracted from narcotized horses (nar-MSCs).
  • Cells were analyzed for specific markers associated with eMSCs, which include positivity for CD44 and CD90, and negativity for CD11a/CD18 and MHCII.

Findings

  • The under-study cells—eut-MSCs and nar-MSCs—revealed the representative eMSC marker profile and possessed tri-lineage differentiation traits.
  • The expression of CD105 and MHCI varied, although no distinct differences were discovered between eut-MSCs and nar-MSCs.
  • While proliferation traits did not differ between eut-MSCs and nar-MSCs, there was an observable decrease in proliferation and increase in MHCI expression with age.

Conclusion and Implications

  • The results indicate that eBM-MSCs from euthanized horses could be effectively utilized for therapeutic applications, including the manufacturing of commercial eBM-MSC products.
  • As such, these findings could significantly contribute to expanding the resources for veterinary regenerative medicine, thus offering potential new treatments for various equine conditions.

Cite This Article

APA
Schröck C, Eydt C, Geburek F, Kaiser L, Päbst F, Burk J, Pfarrer C, Staszyk C. (2017). Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia. Vet Med Sci, 3(4), 239-251. https://doi.org/10.1002/vms3.74

Publication

Veterinary medicine and science
ISSN: 2053-1095
NlmUniqueID: 101678837
Country: England
Language: English
Volume: 3
Issue: 4
Pages: 239-251

Researcher Affiliations

Schröck, Carmen
  • Institute for Veterinary Anatomy, -Histology and -EmbryologyJustus-Liebig-UniversityGiessenGermany.
Eydt, Carina
  • Institute of AnatomyUniversity of Veterinary Medicine HannoverHannoverGermany.
Geburek, Florian
  • Clinic for HorsesJustus-Liebig-UniversityGiessenGermany.
Kaiser, Lena
  • Institute for Veterinary Anatomy, -Histology and -EmbryologyJustus-Liebig-UniversityGiessenGermany.
Päbst, Felicitas
  • Translational Centre for Regenerative Medicine (TRM)University of LeipzigLeipzigGermany.
  • Faculty of Veterinary MedicineLarge Animal Clinic for SurgeryUniversity of LeipzigLeipzigGermany.
Burk, Janina
  • Translational Centre for Regenerative Medicine (TRM)University of LeipzigLeipzigGermany.
  • Faculty of Veterinary MedicineLarge Animal Clinic for SurgeryUniversity of LeipzigLeipzigGermany.
Pfarrer, Christiane
  • Institute of AnatomyUniversity of Veterinary Medicine HannoverHannoverGermany.
Staszyk, Carsten
  • Institute for Veterinary Anatomy, -Histology and -EmbryologyJustus-Liebig-UniversityGiessenGermany.

References

This article includes 34 references
  1. Caplan AI. Why are MSCs therapeutic? New data: new insight.. J Pathol 2009 Jan;217(2):318-24.
    pubmed: 19023885doi: 10.1002/path.2469google scholar: lookup
  2. Arnhold SJ, Goletz I, Klein H, Stumpf G, Beluche LA, Rohde C, Addicks K, Litzke LF. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells.. Am J Vet Res 2007 Oct;68(10):1095-105.
    pubmed: 17916017doi: 10.2460/ajvr.68.10.1095google scholar: lookup
  3. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.. Stem Cells 2004;22(5):675-82.
    pubmed: 15342932doi: 10.1634/stemcells.22-5-675google scholar: lookup
  4. Bourzac C, Smith LC, Vincent P, Beauchamp G, Lavoie JP, Laverty S. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols.. Equine Vet J 2010 Sep;42(6):519-27.
    pubmed: 20716192doi: 10.1111/j.2042-3306.2010.00098.xgoogle scholar: lookup
  5. Brehm W. Equine mesenchymal stem cells for the treatment of tendinous lesions in the horse.. IVIS, 10th International Congress of World Equine Veterinary Association 2008.
  6. Brems R, Jebe E. Comparison of treatments with autolog; cultured stem cells from adipose tissue or bone marrow.. IVIS, 10th International Congress of World Equine Veterinary Association 2008.
  7. Burk J, Badylak SF, Kelly J, Brehm W. Equine cellular therapy--from stall to bench to bedside?. Cytometry A 2013 Jan;83(1):103-13.
    pubmed: 23081833doi: 10.1002/cyto.a.22216google scholar: lookup
  8. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species.. Comp Med 2013 Jun;63(3):207-17.
    pmc: PMC3690426pubmed: 23759523
  9. Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.. J Pediatr 2014 May;164(5):966-972.e6.
    pubmed: 24508444doi: 10.1016/j.jpeds.2013.12.011google scholar: lookup
  10. Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, Spadari A, Galli C, Lazzari G. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor.. Vet Res Commun 2009 Dec;33(8):811-21.
    pubmed: 19472068doi: 10.1007/s11259-009-9229-0google scholar: lookup
  11. Cortes Y, Ojeda M, Araya D, Dueñas F, Fernández MS, Peralta OA. Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses.. BMC Vet Res 2013 Jul 5;9:133.
    pmc: PMC3751243pubmed: 23826829doi: 10.1186/1746-6148-9-133google scholar: lookup
  12. Dixon WJ. BMDP Statistical Software Manual, Volume 1 and 2. University of California Press, Berkeley, Los Angeles, London, 1993.
  13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
  14. Durando MM, Zarucco L, Schaer TP, Ross P, Reef VB. Pneumopericardium in a horse secondary to sternal bone marrow aspiration.. Equine Veterinary Education 18, 75–79, 2006.
  15. Eydt C, Schröck C, Geburek F, Rohn K, Staszyk C, Pfarrer C. Three-dimensional anatomy of the equine sternum.. Anat Histol Embryol 2015 Apr;44(2):99-106.
    pubmed: 24712337doi: 10.1111/ahe.12114google scholar: lookup
  16. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.. J Orthop Res 2009 Dec;27(12):1675-80.
    pubmed: 19544397doi: 10.1002/jor.20933google scholar: lookup
  17. Gilbert PM, Blau HM. Engineering a stem cell house into a home.. Stem Cell Res Ther 2011 Jan 31;2(1):3.
    doi: 10.1186/scrt44pmc: PMC3092143pubmed: 21345268google scholar: lookup
  18. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.. Equine Vet J 2008 Mar;40(2):178-81.
    pubmed: 18267891doi: 10.2746/042516408x276942google scholar: lookup
  19. Heng TS, Dudakov JA, Khong DM, Chidgey AP, Boyd RL. Stem cells--meet immunity.. J Mol Med (Berl) 2009 Nov;87(11):1061-9.
    pubmed: 19841876doi: 10.1007/s00109-009-0539-zgoogle scholar: lookup
  20. Iacono E, Merlo B, Pirrone A, Antonelli C, Brunori L, Romagnoli N, Castagnetti C. Effects of mesenchymal stem cells isolated from amniotic fluid and platelet-rich plasma gel on severe decubitus ulcers in a septic neonatal foal.. Res Vet Sci 2012 Dec;93(3):1439-40.
    pubmed: 22579411doi: 10.1016/j.rvsc.2012.04.008google scholar: lookup
  21. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.. Reproduction 2012 Apr;143(4):455-68.
    pubmed: 22274885doi: 10.1530/rep-10-0408google scholar: lookup
  22. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm.. J Cell Physiol 2009 May;219(2):271-5.
    pubmed: 19160417doi: 10.1002/jcp.21690google scholar: lookup
  23. Jacobs RM, Kociba GJ, Ruoff WW. Monoclonal gammopathy in a horse with defective hemostasis.. Vet Pathol 1983 Sep;20(5):643-7.
    pubmed: 6636474doi: 10.1177/030098588302000520google scholar: lookup
  24. Kasashima Y, Ueno T, Tomita A, Goodship AE, Smith RK. Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells.. Equine Vet J 2011 May;43(3):288-94.
    pubmed: 21492205doi: 10.1111/j.2042-3306.2010.00215.xgoogle scholar: lookup
  25. Lange-Consiglio A, Tassan S, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.. Cytotherapy 2013 Aug;15(8):1011-20.
    pubmed: 23602577doi: 10.1016/j.jcyt.2013.03.002google scholar: lookup
  26. Li ZY, Wang CQ, Lu G, Pan XY, Xu KL. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.. Cell Biochem Biophys 2014 Sep;70(1):115-22.
    doi: 10.1007/s12013-014-9866-ypubmed: 24696072google scholar: lookup
  27. Mensing N, Gasse H, Hambruch N, Haeger JD, Pfarrer C, Staszyk C. Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse.. BMC Vet Res 2011 Aug 2;7:42.
    pmc: PMC3161857pubmed: 21810270doi: 10.1186/1746-6148-7-42google scholar: lookup
  28. Rafei M, Birman E, Forner K, Galipeau J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.. Mol Ther 2009 Oct;17(10):1799-803.
    pmc: PMC2835011pubmed: 19602999doi: 10.1038/mt.2009.157google scholar: lookup
  29. Renzi S, Riccò S, Dotti S, Sesso L, Grolli S, Cornali M, Carlin S, Patruno M, Cinotti S, Ferrari M. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.. Res Vet Sci 2013 Aug;95(1):272-7.
    pubmed: 23419936doi: 10.1016/j.rvsc.2013.01.017google scholar: lookup
  30. Roemeling-van Rhijn M, Khairoun M, Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG, Genever PG, van Kooten C, de Fijter HJ, Rabelink TJ, Baan CC, Weimar W, Roelofs H, Hoogduijn MJ, Reinders ME. Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.. J Stem Cell Res Ther 2013 Nov 25;Suppl 6(1):20780.
    pmc: PMC3963708pubmed: 24672744doi: 10.4172/2157-7633.s6-001google scholar: lookup
  31. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.. PLoS One 2013;8(9):e75697.
    pmc: PMC3783421pubmed: 24086616doi: 10.1371/journal.pone.0075697google scholar: lookup
  32. Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells.. Vet J 2013 Jan;195(1):107-13.
    pubmed: 22717781doi: 10.1016/j.tvjl.2012.05.006google scholar: lookup
  33. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells.. Vet Surg 2007 Oct;36(7):613-22.
    pubmed: 17894587doi: 10.1111/j.1532-950x.2007.00313.xgoogle scholar: lookup
  34. Watts AE, Yeager AE, Kopyov OV, Nixon AJ. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.. Stem Cell Res Ther 2011 Jan 27;2(1):4.
    doi: 10.1186/scrt45pmc: PMC3092144pubmed: 21272343google scholar: lookup

Citations

This article has been cited 3 times.
  1. Bagge J, Berg LC, Janes J, MacLeod JN. Donor age effects on in vitro chondrogenic and osteogenic differentiation performance of equine bone marrow- and adipose tissue-derived mesenchymal stromal cells. BMC Vet Res 2022 Nov 3;18(1):388.
    doi: 10.1186/s12917-022-03475-2pubmed: 36329434google scholar: lookup
  2. Trachsel DS, Stage HJ, Rausch S, Trappe S, Söllig K, Sponder G, Merle R, Aschenbach JR, Gehlen H. Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine. Animals (Basel) 2022 Aug 11;12(16).
    doi: 10.3390/ani12162049pubmed: 36009640google scholar: lookup
  3. Bagge J, MacLeod JN, Berg LC. Cellular Proliferation of Equine Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells Decline With Increasing Donor Age. Front Vet Sci 2020;7:602403.
    doi: 10.3389/fvets.2020.602403pubmed: 33363241google scholar: lookup
Subscribe to our newsletter
Join 99,093 horse owners like you who receive our email updates on horse health and nutrition.